Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA)
Clinical trial NCT02319759 · COMPLETED
Trial details
- NCT number
- NCT02319759
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-27
- Primary completion
- 2016-05-31
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.